Replimune Group, Inc. (REPL)
7.86
+0.08
(+1.09%)
USD |
NASDAQ |
Feb 10, 12:43
Replimune Group Price : 7.86 for Feb. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CorMedix, Inc. | 7.80 |
| Verastem, Inc. | 6.38 |
| Sarepta Therapeutics, Inc. | 18.39 |
| Anavex Life Sciences Corp. | 4.23 |
| Ocugen, Inc. | 1.46 |
Price Related Metrics
| PEG Ratio | -0.1572 |
| Price to Book Value | 3.083 |
| Earnings Yield | -45.58% |
| Market Cap | 649.02M |
| PEGY Ratio | -0.1572 |